Le Lézard
Classified in: Health, Science and technology
Subject: PER

Kneat Welcomes Global Technology Leader to its Executive Team

LIMERICK, Ireland, June 9, 2023 /CNW/ - kneat.com, inc. (the "Company" or "Kneat") (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that it has appointed Colum McNamara as its Senior Vice President of Global Operations.

An accomplished business leader, Colum has more than 25 years' experience in information technology, having served in varying leadership positions including Customer Success, Technical Support, Network Operations, and overall general management.

Colum joins Kneat from cloud computing and virtualization technology company Citrix, where he served for three years as Senior Director of Customer Success for the EMEA region and was Site Leader of Citrix's Dublin office. Previously, Colum spent five years as Citrix's EMEA Senior Director of Technical Support, leading front line, escalation and development support and project teams to streamline daily operations. Before joining Citrix, Colum was most recently Senior Director of Network Operations with cybersecurity company Irdeto. Colum has also spent several years working in customer-facing roles, in Malaysia for semiconductor company STATS ChipPAC, and for IBM's Microelectronics Division.

In his role, Colum will be responsible for a single global operations and services team comprised of Professional Services, Strategic Partnerships, Kneat Academy and Customer Support.

"Colum's varied and extensive Operations leadership experience will be hugely beneficial to Kneat as we continue to grow and satisfy the demand we are seeing from our customers and partners," said Eddie Ryan, CEO of Kneat. 

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx SaaS platform. Multiple business work processes can be configured on the platform from equipment to computer validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions, and post-approve final deliverables in a controlled FDA 21 CFR Part 11/ EU Annex 11-compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes "forward-looking information" within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the future profitability of the Company, the ability to access the Facility based on ARR milestones, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.

Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor's own risk.

SOURCE kneat.com, inc.

These press releases may also interest you

at 22:00
The "Global Peptone Market Report and Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. Global peptone market is forecasted to reach a value of $210 million by 2028 from $166.12 million in 2023, growing at a CAGR of...

at 21:58
The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix® (panitumumab), a targeted therapy used in the treatment of colorectal cancer. This landmark...

at 21:15
The radiopharmaceuticals market size is expected to grow by USD 4.61 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at a CAGR of 10.22% during the forecast period, according to Technavio Research. The market...

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that FDA has...

at 19:00
The "Global Liquid Dosage Excipients Growth Opportunities" report has been added to  ResearchAndMarkets.com's offering. The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients...

at 18:46
Colorado Access announces the appointment of Jaime Moreno as the organization's new chief communications and member experience officer. This newly created position at Colorado Access is a testament to the organization's commitment to providing the...

News published on and distributed by: